Related Experiment Video
Updated: May 8, 2025

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages
Published on: May 21, 2018
Inflammasomes and idiopathic inflammatory myopathies
Rui Sun1, Jiyan Chu1,2, Ping Li1
1Department of Rheumatology, General Hospital of Northern Theater Command, Shenyang, Liaoning, China.
Idiopathic inflammatory myopathies involve inflammasomes, like NLRP3, triggering muscle damage and inflammation via pyroptosis. Targeting NLRP3 may offer new treatments for these autoimmune muscle diseases.
Area of Science:
- Immunology
- Rheumatology
- Cell Biology
Background:
- Idiopathic inflammatory myopathies (IIM) are autoimmune diseases causing muscle weakness.
- The innate immune system, especially inflammasomes, plays a key role in IIM pathogenesis.
- Inflammasomes are protein complexes that regulate inflammatory responses.
Purpose of the Study:
- To review the role of inflammasomes, specifically NLRP3 and AIM2, in IIM development.
- To elucidate the mechanisms of pyroptosis and its link to IIM pathophysiology.
- To explore therapeutic strategies targeting inflammasomes in IIM.
Main Methods:
- Literature review focusing on inflammasome pathways in IIM.
- Analysis of molecular mechanisms of pyroptosis and caspase activation.
- Examination of preclinical data on inflammasome inhibitors.
Main Results:
- NLRP3 inflammasome activation contributes to muscle fiber necrosis and inflammation via damage-associated molecular patterns (DAMPs).
- Pyroptosis, a programmed cell death pathway, is associated with IIM pathogenesis.
- Caspase-1 is a key mediator in the canonical pyroptotic pathway relevant to IIM.
Conclusions:
- Targeting the NLRP3 inflammasome with inhibitors like glyburide and MCC950 shows therapeutic potential for IIM.
- Understanding inflammasome-mediated pyroptosis provides new insights into IIM pathophysiology.
- Further research into inflammasome pathways could lead to novel IIM treatments.
Related Concept Videos
Caspases
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
The JAK-STAT Signaling Pathway
Types of Intermediate Filaments
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Regulation of the Unfolded Protein Response

